ME
23andMe Holding Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.61
+0.00%Leverage
- Debt / equity
- 0.83x
- Net debt / equity
- -0.39x
- Debt / assets
- 0.19x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 0.09x
Liquidity & coverage
- Current ratio
- 0.81x
- Quick ratio
- 0.69x
- Cash ratio
- 0.36x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$21.4M
Cash & dividend
- FCF / debt
- -5.94x
- Cash flow / debt
- -5.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2025